Matthew B. Murphy

Insider Reports History

Entity
Individual
Location
C/O Nautilus Biotechnology, Inc., 425 Pontius Ave N, Ste 202, Seattle, WA
Signature
/s/ Matthew B. Murphy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew B. Murphy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nautilus Biotechnology, Inc. General Counsel Stock Option (Right to Buy) 160K Mar 1, 2024 Direct

Insider Reports Filed by Matthew B. Murphy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NAUT Nautilus Biotechnology, Inc. Mar 1, 2024 1 $0 4 Mar 5, 2024 General Counsel
NAUT Nautilus Biotechnology, Inc. Feb 27, 2023 1 $0 4 Mar 1, 2023 General Counsel
NAUT Nautilus Biotechnology, Inc. Aug 12, 2022 2 $28.4K 4 Aug 16, 2022 General Counsel
NAUT Nautilus Biotechnology, Inc. May 12, 2022 1 $32.8K 4 May 13, 2022 General Counsel
NAUT Nautilus Biotechnology, Inc. Feb 25, 2022 1 $0 4 Feb 25, 2022 General Counsel
NAUT Nautilus Biotechnology, Inc. Aug 13, 2021 1 $37.8K 4 Aug 13, 2021 General Counsel
NAUT Nautilus Biotechnology, Inc. Jun 14, 2021 1 $0 4 Aug 4, 2021 General Counsel
NAUT Nautilus Biotechnology, Inc. Jun 9, 2021 0 $0 3 Jun 9, 2021 General Counsel